Literature DB >> 20882349

Voice disorders in children with classic galactosemia.

Nancy L Potter1.   

Abstract

Children with classic galactosemia are at risk for motor speech disorders resulting from disruptions in motor planning and programming (childhood apraxia of speech or CAS) or motor execution (dysarthria). In the present study of 33 children with classic galactosemia, 21% were diagnosed with CAS, 3% with ataxic dysarthria, and 3% with mixed CAS-dysarthria. Voice disorders due to laryngeal insufficiency were common in children with dysarthria and co-occurred with CAS. Most (58%) of the children with classic galactosemia had decreased respiratory-phonatory support for speech, and 33% had disturbed vocal quality that was indicative of cerebellar dysfunction. Three children, two diagnosed with CAS and one not diagnosed with a motor speech disorder, had vocal tremors. Treatment of voice dysfunction in neurogenic speech disorders is discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20882349      PMCID: PMC3063853          DOI: 10.1007/s10545-010-9213-4

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  26 in total

Review 1.  Toward an acoustic typology of motor speech disorders.

Authors:  Ray D Kent; Y J Kim
Journal:  Clin Linguist Phon       Date:  2003-09       Impact factor: 1.346

2.  Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study.

Authors:  Shimon Sapir; Jennifer Spielman; Lorraine O Ramig; Stephanie L Hinds; Stefanie Countryman; Cynthia Fox; Brad Story
Journal:  Am J Speech Lang Pathol       Date:  2003-11       Impact factor: 2.408

3.  Speech and language deficits in early-treated children with galactosemia.

Authors:  S E Waisbren; T R Norman; R R Schnell; H L Levy
Journal:  J Pediatr       Date:  1983-01       Impact factor: 4.406

4.  Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.

Authors:  L O Ramig; S Sapir; S Countryman; A A Pawlas; C O'Brien; M Hoehn; L L Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-10       Impact factor: 10.154

5.  Prevalence and phenotype of childhood apraxia of speech in youth with galactosemia.

Authors:  Lawrence D Shriberg; Nancy L Potter; Edythe A Strand
Journal:  J Speech Lang Hear Res       Date:  2010-10-21       Impact factor: 2.297

6.  Ataxic dysarthria.

Authors:  R D Kent; J F Kent; J R Duffy; J E Thomas; G Weismer; S Stuntebeck
Journal:  J Speech Lang Hear Res       Date:  2000-10       Impact factor: 2.297

7.  Verbal dyspraxia and galactosemia.

Authors:  Amy Leigh Webb; Rani H Singh; Mary Jane Kennedy; Louis J Elsas
Journal:  Pediatr Res       Date:  2003-03       Impact factor: 3.756

8.  Voice dysfunction in dysarthria: application of the Multi-Dimensional Voice Program.

Authors:  R D Kent; H K Vorperian; J F Kent; J R Duffy
Journal:  J Commun Disord       Date:  2003 Jul-Aug       Impact factor: 2.288

9.  Curious neurologic sequelae in galactosemia.

Authors:  W Lo; S Packman; S Nash; K Schmidt; S Ireland; I Diamond; W Ng; G Donnell
Journal:  Pediatrics       Date:  1984-03       Impact factor: 7.124

10.  Acoustic investigation of vocal quality following treatment for childhood cerebellar tumour.

Authors:  Petrea L Cornwell; Bruce E Murdoch; Elizabeth C Ward; Stewart Kellie
Journal:  Folia Phoniatr Logop       Date:  2004 Mar-Apr       Impact factor: 0.849

View more
  8 in total

1.  Classical Galactosaemia in Ireland: incidence, complications and outcomes of treatment.

Authors:  K P Coss; P P Doran; C Owoeye; M B Codd; N Hamid; P D Mayne; E Crushell; I Knerr; A A Monavari; E P Treacy
Journal:  J Inherit Metab Dis       Date:  2012-07-03       Impact factor: 4.982

2.  Galactokinase deficiency in a patient with congenital hyperinsulinism.

Authors:  Mashbat Bayarchimeg; Dunia Ismail; Amanda Lam; Derek Burk; Jeremy Kirk; Wolfgang Hogler; Sarah E Flanagan; Sian Ellard; Khalid Hussain
Journal:  JIMD Rep       Date:  2011-12-13

3.  Motor and speech disorders in classic galactosemia.

Authors:  Nancy L Potter; Yves Nievergelt; Lawrence D Shriberg
Journal:  JIMD Rep       Date:  2013-04-02

4.  Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia.

Authors:  Emily L Ryan; Mary Ellen Lynch; Elles Taddeo; Tyler J Gleason; Michael P Epstein; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2013-01-15       Impact factor: 4.982

5.  White matter microstructure pathology in classic galactosemia revealed by neurite orientation dispersion and density imaging.

Authors:  Inge Timmers; Hui Zhang; Matteo Bastiani; Bernadette M Jansma; Alard Roebroeck; M Estela Rubio-Gozalbo
Journal:  J Inherit Metab Dis       Date:  2014-10-25       Impact factor: 4.982

6.  Exploration of the Brain in Rest: Resting-State Functional MRI Abnormalities in Patients with Classic Galactosemia.

Authors:  Britt van Erven; Bernadette M Jansma; M Estela Rubio-Gozalbo; Inge Timmers
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

Review 7.  Sweet and sour: an update on classic galactosemia.

Authors:  Ana I Coelho; M Estela Rubio-Gozalbo; João B Vicente; Isabel Rivera
Journal:  J Inherit Metab Dis       Date:  2017-03-09       Impact factor: 4.982

8.  From mind to mouth: event related potentials of sentence production in classic galactosemia.

Authors:  Inge Timmers; Bernadette M Jansma; M Estela Rubio-Gozalbo
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.